Publications
- Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes2023 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, Central Library of Charles University
- Diabetic Macular Edema - Diagnostics and Treatment Guidelines2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial2023 | Third Faculty of Medicine, Central Library of Charles University
- Diabetic Retinopathy - Diagnostics and Treatment Guidelines2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Diabetic Retinopathy and Diabetic Macular Edema - Screening2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial2023 | Third Faculty of Medicine, Central Library of Charles University
- Aflibercept for Vascularised Serous Pigment Epithelial Detachment: One-Year Anatomical and Functional Results2020 | First Faculty of Medicine
- The Burden of Macular Diseases in Central and Eastern Europe-Implications for Healthcare Systems2019 | Third Faculty of Medicine, Central Library of Charles University
- Assessment of the Efficacy of Photodynamic Therapy in Patients with Chronic Central Serous Chorioretinopathy2019 | First Faculty of Medicine
- New trends in the treatment of proliferative diabetic retinopathy2018 | First Faculty of Medicine
Loading network view...